Jan Grimm
Member of the Board
Neurobiology, immunology and diabetes
Neurimmune
Switzerland
Biography
Jan Grimm is a neuroscientist with 15 years of experience in drug discovery and development in US and European biotech. Dr. Grimm co-founded Neurimmune in 2006 and served as the company's founding CEO. Before joining Neurimmune he led the Alzheimer’s disease research efforts at Rinat Neuroscience Corp. in San Francisco that was acquired by Pfizer in 2006.
Research Interest
He received his PhD from Max Delbrück Center for Molecular Medicine and Humboldt University Berlin.
